Literature DB >> 7665227

Human papillomavirus and cervical neoplasia: a case-control study in Taiwan.

K L Liaw1, A W Hsing, C J Chen, M H Schiffman, T Y Zhang, C Y Hsieh, C E Greer, S L You, T W Huang, T C Wu.   

Abstract

As part of a large-scale, community-based cervical neoplasia screening project in rural Taiwan, a case-control study was undertaken to evaluate the etiologic role of human papillomavirus (HPV) infection in this mainly monogamous (2% reported having multiple sexual partners) female population. A total of 88 biopsy-confirmed cases and 261 cytologically normal controls were selected for the study. The case group included 40 cases of cervical intraepithelial neoplasia (CIN) 1, 9 of CIN 2, 36 of CIN 3 and 3 cases of invasive cancer. Cervical swabs collected at screening from study subjects were tested for HPV DNA by an LI consensus primer polymerase chain reaction (PCR)-based technique. HPV DNA was found in 92% of high-grade cases (CIN 2-3 and invasive cancer); 54% of low-grade cases (CIN 1); and 9% of controls. HPV was significantly associated with both high-grade and low-grade cervical neoplasia. As reported in Western countries, HPV 16 was the predominant type among HPV-positive high-grade cases. However, HPVs 52 and/or 58 combined were the most common types among HPV-positive low-grade cases and controls. Among women without any high-risk HPV infection (types 16, 18, 31 or 45), those with multiple-type HPV infection had a higher risk for high-grade cervical neoplasia than those with single-type infection. Overall, 91% of high-grade cases and 50% of low-grade cases could be attributed to HPV infection. Our results show that, even in this monogamous population, HPV is the major risk factor for high-grade cervical neoplasia.

Entities:  

Mesh:

Year:  1995        PMID: 7665227     DOI: 10.1002/ijc.2910620513

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.

Authors:  W Qu; G Jiang; Y Cruz; C J Chang; G Y Ho; R S Klein; R D Burk
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

2.  Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method.

Authors:  P E Gravitt; C L Peyton; R J Apple; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

3.  Persistence of type-specific human papillomavirus infection and increased long-term risk of cervical cancer.

Authors:  Hui-Chi Chen; Mark Schiffman; Ching-Yu Lin; Mei-Hung Pan; San-Lin You; Li-Chung Chuang; Chang-Yao Hsieh; Kai-Li Liaw; Ann W Hsing; Chien-Jen Chen
Journal:  J Natl Cancer Inst       Date:  2011-09-06       Impact factor: 13.506

4.  Prevalence of human papillomavirus in university young women.

Authors:  Maria T Montalvo; Ismelda Lobato; Hilda Villanueva; Celia Borquez; Daniela Navarrete; Juan Abarca; Gloria M Calaf
Journal:  Oncol Lett       Date:  2011-04-06       Impact factor: 2.967

5.  From human papillomavirus (HPV) to cervical cancer: psychosocial processes in infection, detection, and control.

Authors:  S M Miller; W Mischel; A O'Leary; M Mills
Journal:  Ann Behav Med       Date:  1996

6.  The physical state of HPV16 infection and its clinical significance in cancer precursor lesion and cervical carcinoma.

Authors:  Wei Li; Wei Wang; Mani Si; Linfei Han; Qinglei Gao; Aiyue Luo; Yan Li; Yunping Lu; Shixuan Wang; Ding Ma
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-14       Impact factor: 4.553

7.  Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan.

Authors:  Pang-Hsiang Liu; Fu-Chang Hu; Ping-Ing Lee; Song-Nan Chow; Chao-Wan Huang; Jung-Der Wang
Journal:  BMC Health Serv Res       Date:  2010-01-11       Impact factor: 2.655

8.  Cost-effectiveness of a potential vaccine for human papillomavirus.

Authors:  Gillian D Sanders; Al V Taira
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

9.  Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61).

Authors:  Zigui Chen; Mark Schiffman; Rolando Herrero; Rob DeSalle; Kathryn Anastos; Michel Segondy; Vikrant V Sahasrabuddhe; Patti E Gravitt; Ann W Hsing; Paul K S Chan; Robert D Burk
Journal:  Virology       Date:  2018-01-11       Impact factor: 3.616

10.  Human papillomavirus type 58: the unique role in cervical cancers in East Asia.

Authors:  Paul Ks Chan
Journal:  Cell Biosci       Date:  2012-05-09       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.